Crossmark

Optimal dosing of cytarabine in induction and post-remission therapy of acute myeloid leukemia

Published Online: 2020-12-16

Published Print: 2021-02

Authors

Walter, Roland B. https://orcid.org/0000-0002-9268-3341
Appelbaum, Frederick R.

Estey, Elihu H.
License Information

Text and Data Mining valid from 2020-12-16

Version of Record valid from 2020-12-16
More Information

Article History

Received: 11 November 2020

Revised: 20 November 2020

Accepted: 1 December 2020

First Online: 16 December 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current